Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia

Wen Ching Huang, Yi Ming Chen, Nai Wen Kan, Chun Sheng Ho, Li Wei, Ching Hung Chan, Hui Yu Huang, Chi Chang Huang

研究成果: 雜誌貢獻文章

14 引文 (Scopus)

摘要

We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2% cholesterol and 10% lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 109 cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect.
原文英語
頁(從 - 到)3767-3782
頁數16
期刊Nutrients
7
發行號5
DOIs
出版狀態已發佈 - 五月 15 2015

指紋

Lactobacillus reuteri
hyperlipidemia
Hyperlipidemias
hamsters
Cricetinae
Cholesterol
Safety
cholesterol
high fat diet
low density lipoprotein cholesterol
high density lipoprotein cholesterol
triacylglycerols
Diet
Triglycerides
LDL Cholesterol
HDL Cholesterol
liver
Serum
Liver
lard

ASJC Scopus subject areas

  • Food Science

引用此文

Huang, W. C., Chen, Y. M., Kan, N. W., Ho, C. S., Wei, L., Chan, C. H., ... Huang, C. C. (2015). Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia. Nutrients, 7(5), 3767-3782. https://doi.org/10.3390/nu7053767

Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia. / Huang, Wen Ching; Chen, Yi Ming; Kan, Nai Wen; Ho, Chun Sheng; Wei, Li; Chan, Ching Hung; Huang, Hui Yu; Huang, Chi Chang.

於: Nutrients, 卷 7, 編號 5, 15.05.2015, p. 3767-3782.

研究成果: 雜誌貢獻文章

Huang, Wen Ching ; Chen, Yi Ming ; Kan, Nai Wen ; Ho, Chun Sheng ; Wei, Li ; Chan, Ching Hung ; Huang, Hui Yu ; Huang, Chi Chang. / Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia. 於: Nutrients. 2015 ; 卷 7, 編號 5. 頁 3767-3782.
@article{bdfd5e6f5d6540868b25910bfa978f57,
title = "Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia",
abstract = "We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2{\%} cholesterol and 10{\%} lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 109 cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect.",
keywords = "Cholesterol, High-cholesterol diet, Hypolipidemic, Lipid-lowering, Triglyceride",
author = "Huang, {Wen Ching} and Chen, {Yi Ming} and Kan, {Nai Wen} and Ho, {Chun Sheng} and Li Wei and Chan, {Ching Hung} and Huang, {Hui Yu} and Huang, {Chi Chang}",
year = "2015",
month = "5",
day = "15",
doi = "10.3390/nu7053767",
language = "English",
volume = "7",
pages = "3767--3782",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia

AU - Huang, Wen Ching

AU - Chen, Yi Ming

AU - Kan, Nai Wen

AU - Ho, Chun Sheng

AU - Wei, Li

AU - Chan, Ching Hung

AU - Huang, Hui Yu

AU - Huang, Chi Chang

PY - 2015/5/15

Y1 - 2015/5/15

N2 - We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2% cholesterol and 10% lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 109 cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect.

AB - We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2% cholesterol and 10% lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 109 cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect.

KW - Cholesterol

KW - High-cholesterol diet

KW - Hypolipidemic

KW - Lipid-lowering

KW - Triglyceride

UR - http://www.scopus.com/inward/record.url?scp=84929340008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929340008&partnerID=8YFLogxK

U2 - 10.3390/nu7053767

DO - 10.3390/nu7053767

M3 - Article

C2 - 25988768

AN - SCOPUS:84929340008

VL - 7

SP - 3767

EP - 3782

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 5

ER -